- DOW Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing
Dow (DOW) 8-KRegulation FD Disclosure
Filed: 3 Jun 19, 4:30pm
• | the distribution of AgCo and SpecCo as discontinued operations (see column titled Total - Continuing Operations); |
• | the receipt of ECP, as if it had been consummated on January 1, 2017, which is being voluntarily furnished in the pro forma income statements to conform to the presentation of the unaudited pro forma combined financial information contained in Dow Inc.’s Form 10 filed on March 8, 2019 with the SEC; |
• | the reclassification of transactions between Dow and AgCo and SpecCo from intercompany transactions to trade transactions; |
• | the reclassification of transactions between Dow and ECP from related party transactions (included in “Net sales”) to intercompany transactions; |
• | the 2017 impact of a consummated divestiture agreed to with the European Commission as a condition of approval for the Merger; |
• | the impact of various manufacturing, supply and service related agreements Dow and/or certain of its subsidiaries have entered into with DowDuPont and Corteva, Inc. in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of Historical Dow and Historical DuPont (note that the margin impact of these agreements were not included in the Form 10 but are included in this filing only for first quarter 2019 and fiscal year 2018); |
• | the impact of certain one-time costs related to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions; |
• | the removal of the amortization of ECP’s inventory step-up recognized in connection with the Merger; |
• | additional depreciation and amortization of intangibles related to the step-up in basis of property and intangible assets in connection with the Merger; and |
• | the separate presentation of interest income on the face of the income statement (included in "Sundry income (expense) - net" prior to separation from DowDuPont). |
Three Months Ended | Year Ended | Three Months Ended | Year Ended | Three Months Ended | |||||||||||||||||||||||||||||
In millions, except per share amounts | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Dec 31, 2018 | Mar 31, 2019 | ||||||||||||||||||||||
Net sales | $ | 10,521 | $ | 10,936 | $ | 11,254 | $ | 12,061 | $ | 44,772 | $ | 12,296 | $ | 12,851 | $ | 12,697 | $ | 12,008 | $ | 49,852 | $ | 11,016 | |||||||||||
Cost of sales | 8,586 | 8,969 | 9,129 | 10,029 | 36,713 | 10,022 | 10,591 | 10,505 | 10,152 | 41,270 | 9,174 | ||||||||||||||||||||||
Research and development expenses | 218 | 204 | 203 | 193 | 818 | 210 | 220 | 191 | 177 | 798 | 190 | ||||||||||||||||||||||
Selling, general and administrative expenses | 500 | 446 | 460 | 427 | 1,833 | 482 | 486 | 409 | 404 | 1,781 | 448 | ||||||||||||||||||||||
Amortization of intangibles | 116 | 116 | 116 | 117 | 465 | 119 | 116 | 118 | 116 | 469 | 116 | ||||||||||||||||||||||
Restructuring, goodwill impairment and asset related charges (credits) - net | — | (12 | ) | 118 | 2,636 | 2,742 | 72 | 32 | 48 | 46 | 198 | 156 | |||||||||||||||||||||
Integration and separation costs | 114 | 145 | 212 | 245 | 716 | 207 | 234 | 289 | 344 | 1,074 | 402 | ||||||||||||||||||||||
Equity in earnings (losses) of nonconsolidated affiliates | 110 | 22 | 128 | 138 | 398 | 201 | 193 | 135 | 26 | 555 | (14 | ) | |||||||||||||||||||||
Sundry income (expense) - net | 4 | 251 | 2 | 65 | 322 | 53 | (12 | ) | (4 | ) | 56 | 93 | 69 | ||||||||||||||||||||
Interest income | 16 | 12 | 17 | 21 | 66 | 20 | 19 | 21 | 23 | 83 | 19 | ||||||||||||||||||||||
Interest expense and amortization of debt discount | 213 | 217 | 235 | 250 | 915 | 261 | 262 | 258 | 281 | 1,062 | 240 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes | $ | 904 | $ | 1,136 | $ | 928 | $ | (1,612 | ) | $ | 1,356 | $ | 1,197 | $ | 1,110 | $ | 1,031 | $ | 593 | $ | 3,931 | $ | 364 | ||||||||||
Provision for income taxes on continuing operations | 219 | 276 | 460 | 972 | 1,927 | 236 | 261 | 288 | 62 | 847 | 156 | ||||||||||||||||||||||
Net income (loss) from continuing operations | $ | 685 | $ | 860 | $ | 468 | $ | (2,584 | ) | $ | (571 | ) | $ | 961 | $ | 849 | $ | 743 | $ | 531 | $ | 3,084 | $ | 208 | |||||||||
Net income attributable to noncontrolling interests | 12 | 30 | 23 | 36 | 101 | 21 | 37 | 20 | 24 | 102 | 32 | ||||||||||||||||||||||
Net income (loss) from continuing operations available for Dow Inc. common stockholders | $ | 673 | $ | 830 | $ | 445 | $ | (2,620 | ) | $ | (672 | ) | $ | 940 | $ | 812 | $ | 723 | $ | 507 | $ | 2,982 | $ | 176 | |||||||||
Per common share data: | |||||||||||||||||||||||||||||||||
Earnings (loss) per common share from continuing operations - basic | $ | 0.90 | $ | 1.11 | $ | 0.59 | $ | (3.51 | ) | $ | (0.91 | ) | $ | 1.26 | $ | 1.08 | $ | 0.97 | $ | 0.68 | $ | 3.99 | $ | 0.24 | |||||||||
Earnings (loss) per common share from continuing operations - diluted | $ | 0.89 | $ | 1.09 | $ | 0.59 | $ | (3.51 | ) | $ | (0.91 | ) | $ | 1.26 | $ | 1.08 | $ | 0.97 | $ | 0.68 | $ | 3.99 | $ | 0.24 | |||||||||
Weighted-average common shares outstanding - basic | 739.7 | 745.4 | 746.8 | 747.2 | 744.8 | 747.2 | 747.2 | 747.2 | 747.2 | 747.2 | 747.2 | ||||||||||||||||||||||
Weighted-average common shares outstanding - diluted | 751.7 | 756.0 | 754.2 | 747.2 | 744.8 | 747.2 | 747.2 | 747.2 | 747.2 | 747.2 | 747.2 |
In millions, except per share amounts | Historical Dow 1 | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 2 | Pro Forma | ||||||||||||
Net sales | $ | 13,230 | $ | (3,162 | ) | $ | 10,068 | $ | 436 | $ | 17 | $ | 10,521 | |||||
Cost of sales | 10,194 | (1,902 | ) | 8,292 | 248 | 46 | 8,586 | |||||||||||
Research and development expenses | 419 | (208 | ) | 211 | 7 | — | 218 | |||||||||||
Selling, general and administrative expenses | 759 | (275 | ) | 484 | 16 | — | 500 | |||||||||||
Amortization of intangibles | 155 | (63 | ) | 92 | — | 24 | 116 | |||||||||||
Restructuring and asset related credits - net | (1 | ) | 1 | — | — | — | — | |||||||||||
Integration and separation costs | 109 | — | 109 | 25 | (20 | ) | 114 | |||||||||||
Equity in earnings of nonconsolidated affiliates | 196 | (85 | ) | 111 | (1 | ) | — | 110 | ||||||||||
Sundry income (expense) - net 3 | (469 | ) | 469 | — | 4 | — | 4 | |||||||||||
Interest income 3 | 25 | (9 | ) | 16 | — | — | 16 | |||||||||||
Interest expense and amortization of debt discount | 219 | (6 | ) | 213 | — | — | 213 | |||||||||||
Income from continuing operations before income taxes | $ | 1,128 | $ | (334 | ) | $ | 794 | $ | 143 | $ | (33 | ) | $ | 904 | ||||
Provision for income taxes on continuing operations | 213 | (33 | ) | 180 | 45 | (6 | ) | 219 | ||||||||||
Net income from continuing operations | $ | 915 | $ | (301 | ) | $ | 614 | $ | 98 | $ | (27 | ) | $ | 685 | ||||
Net income attributable to noncontrolling interests | 27 | (15 | ) | 12 | — | — | 12 | |||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 888 | $ | (286 | ) | $ | 602 | $ | 98 | $ | (27 | ) | $ | 673 | ||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 0.90 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 0.89 | ||||||||||||||||
Weighted-average common shares outstanding - basic 4 | 739.7 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 4 | 751.7 |
1. | As a result of the Merger and the adoption of Accounting Standards Update ("ASU") 2017-07, "Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost ("ASU 2017-07"), certain reclassifications of Historical Dow amounts were made from what was originally included in the Quarterly Report on Form 10-Q ("10-Q") for the quarterly period ended March 31, 2017. |
2. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
3. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
4. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow 1 | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 2 | Pro Forma | ||||||||||||
Net sales | $ | 13,834 | $ | (3,330 | ) | $ | 10,504 | $ | 420 | $ | 12 | $ | 10,936 | |||||
Cost of sales | 10,761 | (2,107 | ) | 8,654 | 277 | 38 | 8,969 | |||||||||||
Research and development expenses | 408 | (208 | ) | 200 | 4 | — | 204 | |||||||||||
Selling, general and administrative expenses | 720 | (289 | ) | 431 | 15 | — | 446 | |||||||||||
Amortization of intangibles | 157 | (65 | ) | 92 | — | 24 | 116 | |||||||||||
Restructuring and asset related credits - net | (12 | ) | — | (12 | ) | — | — | (12 | ) | |||||||||
Integration and separation costs | 136 | — | 136 | 26 | (17 | ) | 145 | |||||||||||
Equity in earnings of nonconsolidated affiliates | 54 | (36 | ) | 18 | 4 | — | 22 | |||||||||||
Sundry income (expense) - net 3 | 300 | (58 | ) | 242 | 9 | — | 251 | |||||||||||
Interest income 3 | 22 | (10 | ) | 12 | — | — | 12 | |||||||||||
Interest expense and amortization of debt discount | 226 | (9 | ) | 217 | — | — | 217 | |||||||||||
Income from continuing operations before income taxes | $ | 1,814 | $ | (756 | ) | $ | 1,058 | $ | 111 | $ | (33 | ) | $ | 1,136 | ||||
Provision for income taxes on continuing operations | 455 | (208 | ) | 247 | 34 | (5 | ) | 276 | ||||||||||
Net income from continuing operations | $ | 1,359 | $ | (548 | ) | $ | 811 | $ | 77 | $ | (28 | ) | $ | 860 | ||||
Net income attributable to noncontrolling interests | 38 | (8 | ) | 30 | — | — | 30 | |||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 1,321 | $ | (540 | ) | $ | 781 | $ | 77 | $ | (28 | ) | $ | 830 | ||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 1.11 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 1.09 | ||||||||||||||||
Weighted-average common shares outstanding - basic 4 | 745.4 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 4 | 756.0 |
1. | As a result of the Merger and the adoption of ASU 2017-07, certain reclassifications of Historical Dow amounts were made from what was originally included in the 10-Q for the quarterly period ended June 30, 2017. |
2. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
3. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
4. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow 1 | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 2 | Pro Forma | ||||||||||||
Net sales | $ | 13,633 | $ | (2,831 | ) | $ | 10,802 | $ | 430 | $ | 22 | $ | 11,254 | |||||
Cost of sales | 10,663 | (1,873 | ) | 8,790 | 326 | 13 | 9,129 | |||||||||||
Research and development expenses | 408 | (211 | ) | 197 | 6 | — | 203 | |||||||||||
Selling, general and administrative expenses | 724 | (287 | ) | 437 | 23 | — | 460 | |||||||||||
Amortization of intangibles | 155 | (63 | ) | 92 | 8 | 16 | 116 | |||||||||||
Restructuring and asset related charges - net | 139 | (23 | ) | 116 | 2 | — | 118 | |||||||||||
Integration and separation costs | 283 | — | 283 | 24 | (95 | ) | 212 | |||||||||||
Equity in earnings of nonconsolidated affiliates | 156 | (32 | ) | 124 | 4 | — | 128 | |||||||||||
Sundry income (expense) - net 3 | 241 | (17 | ) | 224 | 5 | (227 | ) | 2 | ||||||||||
Interest income 3 | 27 | (10 | ) | 17 | — | — | 17 | |||||||||||
Interest expense and amortization of debt discount | 256 | (21 | ) | 235 | — | — | 235 | |||||||||||
Income from continuing operations before income taxes | $ | 1,429 | $ | (412 | ) | $ | 1,017 | $ | 50 | $ | (139 | ) | $ | 928 | ||||
Provision for income taxes on continuing operations | 624 | (116 | ) | 508 | 4 | (52 | ) | 460 | ||||||||||
Net income from continuing operations | $ | 805 | $ | (296 | ) | $ | 509 | $ | 46 | $ | (87 | ) | $ | 468 | ||||
Net income attributable to noncontrolling interests | 22 | 1 | 23 | — | — | 23 | ||||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 783 | $ | (297 | ) | $ | 486 | $ | 46 | $ | (87 | ) | $ | 445 | ||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 0.59 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 0.59 | ||||||||||||||||
Weighted-average common shares outstanding - basic 4 | 746.8 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 4 | 754.2 |
1. | As a result of the adoption of ASU 2017-07, certain reclassifications of Historical Dow amounts were made from what was originally included in the 10‑Q for the quarterly period ended September 30, 2017. |
2. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
3. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
4. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow 1 | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 2 | Pro Forma | ||||||||||||
Net sales | $ | 14,811 | $ | (3,235 | ) | $ | 11,576 | $ | 441 | $ | 44 | $ | 12,061 | |||||
Cost of sales | 11,994 | (2,108 | ) | 9,886 | 393 | (250 | ) | 10,029 | ||||||||||
Research and development expenses | 413 | (227 | ) | 186 | 6 | 1 | 193 | |||||||||||
Selling, general and administrative expenses | 717 | (292 | ) | 425 | 6 | (4 | ) | 427 | ||||||||||
Amortization of intangibles | 157 | (64 | ) | 93 | 24 | — | 117 | |||||||||||
Restructuring, goodwill impairment and asset related charges - net | 2,974 | (354 | ) | 2,620 | 16 | — | 2,636 | |||||||||||
Integration and separation costs | 258 | (18 | ) | 240 | 23 | (18 | ) | 245 | ||||||||||
Equity in earnings of nonconsolidated affiliates | 356 | (219 | ) | 137 | 1 | — | 138 | |||||||||||
Sundry income (expense) - net 3 | 17 | (639 | ) | (622 | ) | — | 687 | 65 | ||||||||||
Interest income 3 | 32 | (11 | ) | 21 | — | — | 21 | |||||||||||
Interest expense and amortization of debt discount | 275 | (25 | ) | 250 | — | — | 250 | |||||||||||
Loss from continuing operations before income taxes | $ | (1,572 | ) | $ | (1,016 | ) | $ | (2,588 | ) | $ | (26 | ) | $ | 1,002 | $ | (1,612 | ) | |
Provision for income taxes on continuing operations | 912 | (279 | ) | 633 | (19 | ) | 358 | 972 | ||||||||||
Net loss from continuing operations | $ | (2,484 | ) | $ | (737 | ) | $ | (3,221 | ) | $ | (7 | ) | $ | 644 | $ | (2,584 | ) | |
Net income attributable to noncontrolling interests | 42 | (6 | ) | 36 | — | — | 36 | |||||||||||
Net loss from continuing operations available for Dow Inc. common stockholders | $ | (2,526 | ) | $ | (731 | ) | $ | (3,257 | ) | $ | (7 | ) | $ | 644 | $ | (2,620 | ) | |
Per common share data: | ||||||||||||||||||
Loss per common share from continuing operations - basic | $ | (3.51 | ) | |||||||||||||||
Loss per common share from continuing operations - diluted | $ | (3.51 | ) | |||||||||||||||
Weighted-average common shares outstanding - basic 4 | 747.2 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 4 | 747.2 |
1. | As a result of the adoption of ASU 2017-07, certain reclassifications of Historical Dow amounts were made. |
2. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
3. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
4. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow 1 | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 2 | Pro Forma | ||||||||||||
Net sales | $ | 55,508 | $ | (12,558 | ) | $ | 42,950 | $ | 1,727 | $ | 95 | $ | 44,772 | |||||
Cost of sales | 43,612 | (7,990 | ) | 35,622 | 1,244 | (153 | ) | 36,713 | ||||||||||
Research and development expenses | 1,648 | (854 | ) | 794 | 23 | 1 | 818 | |||||||||||
Selling, general and administrative expenses | 2,920 | (1,143 | ) | 1,777 | 60 | (4 | ) | 1,833 | ||||||||||
Amortization of intangibles | 624 | (255 | ) | 369 | 32 | 64 | 465 | |||||||||||
Restructuring, goodwill impairment and asset related charges - net | 3,100 | (376 | ) | 2,724 | 18 | — | 2,742 | |||||||||||
Integration and separation costs | 786 | (18 | ) | 768 | 98 | (150 | ) | 716 | ||||||||||
Equity in earnings of nonconsolidated affiliates | 762 | (372 | ) | 390 | 8 | — | 398 | |||||||||||
Sundry income (expense) - net 3 | 89 | (245 | ) | (156 | ) | 18 | 460 | 322 | ||||||||||
Interest income 3 | 106 | (40 | ) | 66 | — | — | 66 | |||||||||||
Interest expense and amortization of debt discount | 976 | (61 | ) | 915 | — | — | 915 | |||||||||||
Income from continuing operations before income taxes | $ | 2,799 | $ | (2,518 | ) | $ | 281 | $ | 278 | $ | 797 | $ | 1,356 | |||||
Provision for income taxes on continuing operations | 2,204 | (636 | ) | 1,568 | 64 | 295 | 1,927 | |||||||||||
Net income (loss) from continuing operations | $ | 595 | $ | (1,882 | ) | $ | (1,287 | ) | $ | 214 | $ | 502 | $ | (571 | ) | |||
Net income attributable to noncontrolling interests | 129 | (28 | ) | 101 | — | — | 101 | |||||||||||
Net income (loss) from continuing operations available for Dow Inc. common stockholders | $ | 466 | $ | (1,854 | ) | $ | (1,388 | ) | $ | 214 | $ | 502 | $ | (672 | ) | |||
Per common share data: | ||||||||||||||||||
Loss per common share from continuing operations - basic | $ | (0.91 | ) | |||||||||||||||
Loss per common share from continuing operations - diluted | $ | (0.91 | ) | |||||||||||||||
Weighted-average common shares outstanding - basic 4 | 744.8 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 4 | 744.8 |
1. | As a result of the adoption of ASU 2017-07, certain reclassifications of Historical Dow amounts were made from what was originally included in the Annual Report on Form 10‑K for the year ended December 31, 2017. |
2. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
3. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
4. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 1 | Pro Forma | ||||||||||||
Net sales | $ | 14,899 | $ | (3,120 | ) | $ | 11,779 | $ | 448 | $ | 69 | $ | 12,296 | |||||
Cost of sales | 11,552 | (1,886 | ) | 9,666 | 299 | 57 | 10,022 | |||||||||||
Research and development expenses | 386 | (183 | ) | 203 | 7 | — | 210 | |||||||||||
Selling, general and administrative expenses | 751 | (283 | ) | 468 | 14 | — | 482 | |||||||||||
Amortization of intangibles | 159 | (64 | ) | 95 | 24 | — | 119 | |||||||||||
Restructuring and asset related charges - net | 165 | (82 | ) | 83 | 4 | (15 | ) | 72 | ||||||||||
Integration and separation costs | 202 | — | 202 | 22 | (17 | ) | 207 | |||||||||||
Equity in earnings of nonconsolidated affiliates | 243 | (42 | ) | 201 | — | — | 201 | |||||||||||
Sundry income (expense) - net 2 | 55 | (4 | ) | 51 | 2 | — | 53 | |||||||||||
Interest income 2 | 28 | (8 | ) | 20 | — | — | 20 | |||||||||||
Interest expense and amortization of debt discount | 270 | (9 | ) | 261 | — | — | 261 | |||||||||||
Income from continuing operations before income taxes | $ | 1,740 | $ | (667 | ) | $ | 1,073 | $ | 80 | $ | 44 | $ | 1,197 | |||||
Provision for income taxes on continuing operations | 363 | (153 | ) | 210 | 16 | 10 | 236 | |||||||||||
Net income from continuing operations | $ | 1,377 | $ | (514 | ) | $ | 863 | $ | 64 | $ | 34 | $ | 961 | |||||
Net income attributable to noncontrolling interests | 35 | (14 | ) | 21 | — | — | 21 | |||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 1,342 | $ | (500 | ) | $ | 842 | $ | 64 | $ | 34 | $ | 940 | |||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 1.26 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 1.26 | ||||||||||||||||
Weighted-average common shares outstanding - basic 3 | 747.2 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 3 | 747.2 |
1. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
2. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
3. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 1 | Pro Forma | ||||||||||||
Net sales | $ | 15,793 | $ | (3,454 | ) | $ | 12,339 | $ | 449 | $ | 63 | $ | 12,851 | |||||
Cost of sales | 12,400 | (2,180 | ) | 10,220 | 320 | 51 | 10,591 | |||||||||||
Research and development expenses | 407 | (193 | ) | 214 | 6 | — | 220 | |||||||||||
Selling, general and administrative expenses | 748 | (272 | ) | 476 | 10 | — | 486 | |||||||||||
Amortization of intangibles | 155 | (63 | ) | 92 | 24 | — | 116 | |||||||||||
Restructuring and asset related charges - net | 98 | (56 | ) | 42 | (2 | ) | (8 | ) | 32 | |||||||||
Integration and separation costs | 231 | — | 231 | 31 | (28 | ) | 234 | |||||||||||
Equity in earnings of nonconsolidated affiliates | 231 | (41 | ) | 190 | 3 | — | 193 | |||||||||||
Sundry income (expense) - net 2 | (17 | ) | (1 | ) | (18 | ) | 6 | — | (12 | ) | ||||||||
Interest income 2 | 22 | (3 | ) | 19 | — | — | 19 | |||||||||||
Interest expense and amortization of debt discount | 274 | (12 | ) | 262 | — | — | 262 | |||||||||||
Income from continuing operations before income taxes | $ | 1,716 | $ | (723 | ) | $ | 993 | $ | 69 | $ | 48 | $ | 1,110 | |||||
Provision for income taxes on continuing operations | 406 | (169 | ) | 237 | 13 | 11 | 261 | |||||||||||
Net income from continuing operations | $ | 1,310 | $ | (554 | ) | $ | 756 | $ | 56 | $ | 37 | $ | 849 | |||||
Net income attributable to noncontrolling interests | 31 | 6 | 37 | — | — | 37 | ||||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 1,279 | $ | (560 | ) | $ | 719 | $ | 56 | $ | 37 | $ | 812 | |||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 1.08 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 1.08 | ||||||||||||||||
Weighted-average common shares outstanding - basic 3 | 747.2 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 3 | 747.2 |
1. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
2. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
3. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 1 | Pro Forma | ||||||||||||
Net sales | $ | 14,976 | $ | (2,785 | ) | $ | 12,191 | $ | 418 | $ | 88 | $ | 12,697 | |||||
Cost of sales | 11,933 | (1,814 | ) | 10,119 | 309 | 77 | 10,505 | |||||||||||
Research and development expenses | 373 | (188 | ) | 185 | 6 | — | 191 | |||||||||||
Selling, general and administrative expenses | 672 | (273 | ) | 399 | 10 | — | 409 | |||||||||||
Amortization of intangibles | 155 | (61 | ) | 94 | 24 | — | 118 | |||||||||||
Restructuring and asset related charges - net | 108 | (64 | ) | 44 | 4 | — | 48 | |||||||||||
Integration and separation costs | 278 | — | 278 | 35 | (24 | ) | 289 | |||||||||||
Equity in earnings of nonconsolidated affiliates | 165 | (31 | ) | 134 | 1 | — | 135 | |||||||||||
Sundry income (expense) - net 2 | (15 | ) | 11 | (4 | ) | — | — | (4 | ) | |||||||||
Interest income 2 | 26 | (5 | ) | 21 | — | — | 21 | |||||||||||
Interest expense and amortization of debt discount | 280 | (22 | ) | 258 | — | — | 258 | |||||||||||
Income from continuing operations before income taxes | $ | 1,353 | $ | (388 | ) | $ | 965 | $ | 31 | $ | 35 | $ | 1,031 | |||||
Provision for income taxes on continuing operations | 317 | (53 | ) | 264 | 16 | 8 | 288 | |||||||||||
Net income from continuing operations | $ | 1,036 | $ | (335 | ) | $ | 701 | $ | 15 | $ | 27 | $ | 743 | |||||
Net income attributable to noncontrolling interests | 36 | (16 | ) | 20 | — | — | 20 | |||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 1,000 | $ | (319 | ) | $ | 681 | $ | 15 | $ | 27 | $ | 723 | |||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 0.97 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 0.97 | ||||||||||||||||
Weighted-average common shares outstanding - basic 3 | 747.2 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 3 | 747.2 |
1. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
2. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
3. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 1 | Pro Forma | ||||||||||||
Net sales | $ | 14,610 | $ | (3,069 | ) | $ | 11,541 | $ | 379 | $ | 88 | $ | 12,008 | |||||
Cost of sales | 11,820 | (2,029 | ) | 9,791 | 284 | 77 | 10,152 | |||||||||||
Research and development expenses | 370 | (197 | ) | 173 | 4 | — | 177 | |||||||||||
Selling, general and administrative expenses | 675 | (280 | ) | 395 | 9 | — | 404 | |||||||||||
Amortization of intangibles | 153 | (61 | ) | 92 | 24 | — | 116 | |||||||||||
Restructuring and asset related charges - net | 249 | (209 | ) | 40 | 6 | — | 46 | |||||||||||
Integration and separation costs | 333 | — | 333 | 47 | (36 | ) | 344 | |||||||||||
Equity in earnings of nonconsolidated affiliates | 311 | (286 | ) | 25 | 1 | — | 26 | |||||||||||
Sundry income (expense) - net 2 | 49 | 7 | 56 | — | — | 56 | ||||||||||||
Interest income 2 | 33 | (10 | ) | 23 | — | — | 23 | |||||||||||
Interest expense and amortization of debt discount | 294 | (13 | ) | 281 | — | — | 281 | |||||||||||
Income from continuing operations before income taxes | $ | 1,109 | $ | (569 | ) | $ | 540 | $ | 6 | $ | 47 | $ | 593 | |||||
Provision for income taxes on continuing operations | 199 | (137 | ) | 62 | (10 | ) | 10 | 62 | ||||||||||
Net income from continuing operations | $ | 910 | $ | (432 | ) | $ | 478 | $ | 16 | $ | 37 | $ | 531 | |||||
Net income attributable to noncontrolling interests | 32 | (8 | ) | 24 | — | — | 24 | |||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 878 | $ | (424 | ) | $ | 454 | $ | 16 | $ | 37 | $ | 507 | |||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 0.68 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 0.68 | ||||||||||||||||
Weighted-average common shares outstanding - basic 3 | 747.2 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 3 | 747.2 |
1. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
2. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
3. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 1 | Pro Forma | ||||||||||||
Net sales | $ | 60,278 | $ | (12,428 | ) | $ | 47,850 | $ | 1,694 | $ | 308 | $ | 49,852 | |||||
Cost of sales | 47,705 | (7,909 | ) | 39,796 | 1,212 | 262 | 41,270 | |||||||||||
Research and development expenses | 1,536 | (761 | ) | 775 | 23 | — | 798 | |||||||||||
Selling, general and administrative expenses | 2,846 | (1,108 | ) | 1,738 | 43 | — | 1,781 | |||||||||||
Amortization of intangibles | 622 | (249 | ) | 373 | 96 | — | 469 | |||||||||||
Restructuring and asset related charges - net | 620 | (411 | ) | 209 | 12 | (23 | ) | 198 | ||||||||||
Integration and separation costs | 1,044 | — | 1,044 | 135 | (105 | ) | 1,074 | |||||||||||
Equity in earnings of nonconsolidated affiliates | 950 | (400 | ) | 550 | 5 | — | 555 | |||||||||||
Sundry income (expense) - net 2 | 72 | 13 | 85 | 8 | — | 93 | ||||||||||||
Interest income 2 | 109 | (26 | ) | 83 | — | — | 83 | |||||||||||
Interest expense and amortization of debt discount | 1,118 | (56 | ) | 1,062 | — | — | 1,062 | |||||||||||
Income from continuing operations before income taxes | $ | 5,918 | $ | (2,347 | ) | $ | 3,571 | $ | 186 | $ | 174 | $ | 3,931 | |||||
Provision for income taxes on continuing operations | 1,285 | (512 | ) | 773 | 35 | 39 | 847 | |||||||||||
Net income from continuing operations | $ | 4,633 | $ | (1,835 | ) | $ | 2,798 | $ | 151 | $ | 135 | $ | 3,084 | |||||
Net income attributable to noncontrolling interests | 134 | (32 | ) | 102 | — | — | 102 | |||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 4,499 | $ | (1,803 | ) | $ | 2,696 | $ | 151 | $ | 135 | $ | 2,982 | |||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 3.99 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 3.99 | ||||||||||||||||
Weighted-average common shares outstanding - basic 3 | 747.2 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 3 | 747.2 |
1. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
2. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
3. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
In millions, except per share amounts | Historical Dow | Distribution of AgCo and SpecCo | Total - Continuing Operations | Receipt of ECP | Pro Forma Adjustments 1 | Pro Forma | ||||||||||||
Net sales | $ | 13,582 | $ | (3,020 | ) | $ | 10,562 | $ | 392 | $ | 62 | $ | 11,016 | |||||
Cost of sales | 10,707 | (1,871 | ) | 8,836 | 289 | 49 | 9,174 | |||||||||||
Research and development expenses | 361 | (175 | ) | 186 | 4 | — | 190 | |||||||||||
Selling, general and administrative expenses | 701 | (262 | ) | 439 | 9 | — | 448 | |||||||||||
Amortization of intangibles | 154 | (61 | ) | 93 | 23 | — | 116 | |||||||||||
Restructuring and asset related charges - net | 232 | (78 | ) | 154 | 2 | — | 156 | |||||||||||
Integration and separation costs | 408 | — | 408 | 44 | (50 | ) | 402 | |||||||||||
Equity in earnings (losses) of nonconsolidated affiliates | 13 | (28 | ) | (15 | ) | 1 | — | (14 | ) | |||||||||
Sundry income (expense) - net 2 | 51 | 18 | 69 | — | — | 69 | ||||||||||||
Interest income 2 | 22 | (3 | ) | 19 | — | — | 19 | |||||||||||
Interest expense and amortization of debt discount | 247 | (7 | ) | 240 | — | — | 240 | |||||||||||
Income from continuing operations before income taxes | $ | 858 | $ | (579 | ) | $ | 279 | $ | 22 | $ | 63 | $ | 364 | |||||
Provision for income taxes on continuing operations | 272 | (134 | ) | 138 | 4 | 14 | 156 | |||||||||||
Net income from continuing operations | $ | 586 | $ | (445 | ) | $ | 141 | $ | 18 | $ | 49 | $ | 208 | |||||
Net income attributable to noncontrolling interests | 45 | (13 | ) | 32 | — | — | 32 | |||||||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 541 | $ | (432 | ) | $ | 109 | $ | 18 | $ | 49 | $ | 176 | |||||
Per common share data: | ||||||||||||||||||
Earnings per common share from continuing operations - basic | $ | 0.24 | ||||||||||||||||
Earnings per common share from continuing operations - diluted | $ | 0.24 | ||||||||||||||||
Weighted-average common shares outstanding - basic 3 | 747.2 | |||||||||||||||||
Weighted-average common shares outstanding - diluted 3 | 747.2 |
1. | Refer to Summary of Pro Forma Adjustments on page 18 for additional details. |
2. | "Interest income" for Historical Dow was included in "Sundry income (expense) - net" prior to the separation from DowDuPont. |
3. | Refer to Pro Forma Common Shares Outstanding on pages 19-20 for additional details. |
Pro Forma Adjustments | Three Months Ended | Year Ended | Three Months Ended | Year Ended | Three Months Ended | ||||||||||||||||||||||||||||
In millions | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Dec 31, 2018 | Mar 31, 2019 | ||||||||||||||||||||||
Net sales | |||||||||||||||||||||||||||||||||
Intercompany transactions 1 | $ | (3 | ) | $ | (3 | ) | $ | (11 | ) | $ | (16 | ) | $ | (33 | ) | $ | (34 | ) | $ | (35 | ) | $ | (18 | ) | $ | (14 | ) | $ | (101 | ) | $ | (52 | ) |
Manufacturing, supply and service related agreements 2 | 55 | 47 | 56 | 60 | 218 | 103 | 98 | 106 | 102 | 409 | 114 | ||||||||||||||||||||||
Historical divestiture 3 | (35 | ) | (32 | ) | (23 | ) | — | (90 | ) | — | — | — | — | — | — | ||||||||||||||||||
Total net sales | $ | 17 | $ | 12 | $ | 22 | $ | 44 | $ | 95 | $ | 69 | $ | 63 | $ | 88 | $ | 88 | $ | 308 | $ | 62 | |||||||||||
Cost of sales | |||||||||||||||||||||||||||||||||
Intercompany transactions 1 | $ | (3 | ) | $ | (3 | ) | $ | (11 | ) | $ | (16 | ) | $ | (33 | ) | $ | (34 | ) | $ | (35 | ) | $ | (18 | ) | $ | (14 | ) | $ | (101 | ) | $ | (50 | ) |
Manufacturing, supply and service related agreements 2 | 55 | 47 | 56 | 60 | 218 | 91 | 86 | 95 | 91 | 363 | 99 | ||||||||||||||||||||||
Historical divestiture 3 | (22 | ) | (21 | ) | (16 | ) | — | (59 | ) | — | — | — | — | — | — | ||||||||||||||||||
Inventory amortization expense 4 | — | — | (27 | ) | (93 | ) | (120 | ) | — | — | — | — | — | — | |||||||||||||||||||
Pension settlement 5 | — | — | — | (201 | ) | (201 | ) | — | — | — | — | — | — | ||||||||||||||||||||
Depreciation expense 6 | 16 | 15 | 11 | — | 42 | — | — | — | — | — | — | ||||||||||||||||||||||
Total cost of sales | $ | 46 | $ | 38 | $ | 13 | $ | (250 | ) | $ | (153 | ) | $ | 57 | $ | 51 | $ | 77 | $ | 77 | $ | 262 | $ | 49 | |||||||||
Research and development expenses | |||||||||||||||||||||||||||||||||
Depreciation expense 6 | $ | — | $ | — | $ | — | $ | 1 | $ | 1 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||
Selling, general and administrative expenses | |||||||||||||||||||||||||||||||||
Pension settlement 5 | $ | — | $ | — | $ | — | $ | (4 | ) | $ | (4 | ) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||
Amortization of intangibles | |||||||||||||||||||||||||||||||||
Amortization expense 7 | $ | 24 | $ | 24 | $ | 16 | $ | — | $ | 64 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||
Restructuring, goodwill impairment and asset related charges - net | |||||||||||||||||||||||||||||||||
Transaction costs 8 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (15 | ) | $ | (8 | ) | $ | — | $ | — | $ | (23 | ) | $ | — | ||||||||
Integration and separation costs | |||||||||||||||||||||||||||||||||
Transaction costs 8 | $ | (20 | ) | $ | (17 | ) | $ | (95 | ) | $ | (18 | ) | $ | (150 | ) | $ | (17 | ) | $ | (28 | ) | $ | (24 | ) | $ | (36 | ) | $ | (105 | ) | $ | (50 | ) |
Sundry income (expense) - net | |||||||||||||||||||||||||||||||||
Historical divestiture 3 | $ | — | $ | — | $ | (227 | ) | $ | — | $ | (227 | ) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||
Pension settlement 5 | — | — | — | 687 | 687 | — | — | — | — | — | — | ||||||||||||||||||||||
Total sundry income (expense) - net | $ | — | $ | — | $ | (227 | ) | $ | 687 | $ | 460 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||
Total pro forma adjustments to net income (loss) from continuing operations before income taxes | $ | (33 | ) | $ | (33 | ) | $ | (139 | ) | $ | 1,002 | $ | 797 | $ | 44 | $ | 48 | $ | 35 | $ | 47 | $ | 174 | $ | 63 | ||||||||
Provision (credit) for income taxes on continuing operations 9 | $ | (6 | ) | $ | (5 | ) | $ | (52 | ) | $ | 358 | $ | 295 | $ | 10 | $ | 11 | $ | 8 | $ | 10 | $ | 39 | $ | 14 | ||||||||
Total pro forma adjustments to net income (loss) from continuing operations | $ | (27 | ) | $ | (28 | ) | $ | (87 | ) | $ | 644 | $ | 502 | $ | 34 | $ | 37 | $ | 27 | $ | 37 | $ | 135 | $ | 49 |
1. | Elimination of intercompany transactions between Historical Dow and ECP. |
2. | Reclassification of transactions between Historical Dow and AgCo and SpecCo from intercompany transactions to trade transactions. Also includes the impact of various manufacturing, supply and service related agreements Dow entered into with DowDuPont and Corteva, Inc. which provide for different pricing than the historical intercompany and intracompany pricing practices of Historical Dow and Historical DuPont (for 2019 and 2018 only). |
3. | Elimination of the impact of a consummated divestiture agreed to with the European Commission as a condition of approval for the Merger. |
4. | Elimination of the amortization of ECP's inventory step-up recognized in connection with the Merger. |
5. | Elimination of the one-time cost related to the payment of plan obligations of a U.S. non-qualified pension plan upon a change of control of Historical Dow, which occurred at the time of the Merger. |
6. | Increase in depreciation expense for the fair value step-up of ECP's property, plant and equipment in connection with the Merger. |
7. | Increase in amortization expense for the fair value step-up of ECP's finite-lived intangible assets in connection with the Merger. |
8. | Elimination of one-time transaction costs directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions. |
9. | Represents the income tax effect of the pro forma adjustments calculated using a blended statutory income tax rate, inclusive of state taxes. Management believes the blended statutory income tax rate resulting from this calculation provides a reasonable basis for the pro forma adjustments, however the effective tax rate of Dow could be significantly different depending on the mix of activities. |
Pro Forma Net Income from Continuing Operations for Earnings Per Common Share for Pre-Merger Periods | Three months ended | |||||
Mar 31, 2017 | Jun 30, 2017 | |||||
In millions | ||||||
Net income from continuing operations available for Dow Inc. common stockholders | $ | 673 | $ | 830 | ||
Less: Net income attributable to participating securities | 4 | 5 | ||||
Net income from continuing operations attributable to Dow Inc. common stockholders | $ | 669 | $ | 825 |
Pre-Merger Periods Conversion Factor | ||
Shares in millions | ||
Dow common shares outstanding at distribution 1 | 747.2 | |
Divided by: Historical Dow common shares outstanding prior to Merger 2 | 1,214.8 | |
Conversion factor | 0.6151 |
1. | Calculated using the same method as post-Merger periods (see page 20 for calculation). |
2. | Reflects 1,225.3 million Historical Dow common shares outstanding immediately prior to the effective time of the Merger, less 10.5 million Employee Stock Ownership Plan (“ESOP”) shares that had not been released and were not considered outstanding. |
Share Count Information for Pre-Merger Periods | Three Months Ended | |||
Mar 31, 2017 | Jun 30, 2017 | |||
Shares in millions | ||||
Historical Dow common shares outstanding - basic | 1,202.5 | 1,211.8 | ||
Conversion factor | 0.6151 | 0.6151 | ||
Dow common shares outstanding - basic | 739.7 | 745.4 | ||
Historical Dow common shares outstanding - diluted | 1,222.1 | 1,229.0 | ||
Conversion factor | 0.6151 | 0.6151 | ||
Dow common shares outstanding - diluted | 751.7 | 756.0 |
Pro Forma Net Income (Loss) from Continuing Operations for Earnings (Loss) Per Common Share | Three months ended | Year ended | ||||
Sep 30, 2017 | Dec 31, 2017 | |||||
In millions | ||||||
Net income (loss) from continuing operations available for Dow Inc. common stockholders | $ | 445 | $ | (672 | ) | |
Less: Net income attributable to participating securities | 3 | 8 | ||||
Net income (loss) from continuing operations attributable to Dow Inc. common stockholders | $ | 442 | $ | (680 | ) |
Share Count Information | Three months ended | Year ended | ||
Sep 30, 2017 | Dec 31, 2017 | |||
Shares in millions | ||||
Post-Merger period Dow common shares outstanding - basic 1 | 747.2 | 747.2 | ||
Adjustment for pre-Merger Historical Dow common shares outstanding - basic 2 | (0.4 | ) | (2.4 | ) |
Dow common shares outstanding - basic | 746.8 | 744.8 | ||
Dilutive effect 3 | 7.4 | N/A | ||
Dow common shares outstanding - diluted | 754.2 | 744.8 |
1. | Calculated using the same method as post-Merger periods (see table below for calculation). |
2. | Adjustment for the pre-Merger Historical Dow common shares outstanding and the weighting of share counts between pre- and post-Merger periods. |
3. | For the three months ended September 30, 2017, the dilutive effect was calculated using a weighted average of the third quarter of 2017 Historical Dow diluted shares between pre- and post-Merger periods. For the year ended December 31, 2017, pro forma results reflected a net loss, and as such, the basic share count was used for purposes of calculating pro forma loss from continuing operations per common share on a diluted basis. |
Share Count Information for Post-Merger Periods | ||
Shares in millions | ||
DowDuPont common shares outstanding 1 | 2,241.7 | |
Distribution ratio | 1:3 | |
Dow common shares outstanding - basic | 747.2 | |
Dilutive effect 2 | N/A | |
Dow common shares outstanding - diluted | 747.2 |
1. | Based on 2,246.3 million DowDuPont common shares outstanding as of the March 21, 2019 Record Date for the April 1, 2019 distribution, less 4.6 million ESOP shares that had not been released and were not considered outstanding. |
2. | There is no dilutive effect for these periods as Historical Dow did not engage in activities giving rise to dilution in the post-Merger periods. |
Business | Applications/Market Segments | Major Products | Key Raw Materials | Key Competitors |
Coatings & Performance Monomers | Acrylic binders for architectural paints and coatings, industrial coatings and paper; adhesives; dispersants; impact modifiers; inks and paints; opacifiers and surfactants for both architectural and industrial applications; plastics additives; processing aids; protective and functional coatings; rheology modifiers | ACOUSTICRYL™ Liquid-Applied Sound Damping Technology; acrylates; ACRYSOL™ Rheology Modifiers; AVANSE™ Acrylic Binders; EVOQUE™ Pre-Composite Polymer; foam cell promoters; FORMASHIELD™ Acrylic Binder; high-quality impact modifiers; MAINCOTE™ Acrylic Epoxy Hybrid; methacrylates; processing aids; RHOPLEX™ Acrylic Resin; TAMOL™ Dispersants; vinyl acetate monomers; weatherable acrylic capstock compounds for thermoplastic and thermosetting materials | Acetone, butyl acrylate, methyl methacrylate, propylene, styrene | Arkema, BASF, Celanese, Evonik, LyondellBasell, Nan Ya, Owens-Corning, Wacker Chemie |
Consumer Solutions | Personal care, color cosmetics, baby care, home care and specialty applications with a key focus on hair care, skin care, sun care, cleansing, as well as fabric, dish, floor, hard surface and air care applications; commercial glazing; electrical and high-voltage insulation; lamp and luminaire modules assembly; oil and gas; paints and inks; release liners, specialty films and tapes; sporting goods; 3D printing | Adhesives and sealants; antifoams and surfactants; coatings and controlled release; coupling agents and crosslinkers; EVOLV3D™ Printing Technology; fluids, emulsions and dispersions;formulating and processing aids; granulation and binders; oils; polymers and emollients; opacifiers; reagents; resins, gels and powders; rheology modifiers; rubber; silicone elastomers; solubility enhancers; aerospace composites; surfactants and solvents; SILASTIC ™ Silicone Elastomers; DOWSIL™ Silicone Products | Hydrochloric acid, methanol, silica, silicon metal | Elkem, Momentive, Shin-Etsu, Wacker Chemie |
Business | Applications/Market Segments | Major Products | Key Raw Materials | Key Competitors |
Industrial Solutions | Broad range of products for specialty applications, including agriculture crop protection offerings, aircraft deicing, solvents for coatings, heat transfer fluids for concentrated solar power, construction, solvents for electronics processing, food preservation, fuel markers, home and personal care, infrastructure applications, lubricant additives, paper, transportation and utilities; energy markets including exploration, production, transmission, refining, mining and gas processing to optimize supply, improve efficiencies and manage emissions | Acetone derivatives, butyl glycol ethers, VERSENE™ Chelants, UCAR™ Deicing Fluids, ethanolamines, ethylene oxide, ethyleneamines, UCON™ Fluids, glycol ethers, UCARTHERM™ Heat Transfer Fluids, higher glycols, isopropanolamines, low-VOC solvents, methoxypolyethylene glycol, methyl isobutyl, polyalkylene glycol, CARBOWAX™ SENTRY™ Polyethylene Glycol, TERGITOL™ and TRITON™ Surfactants, demulsifiers, drilling and completion fluids, heat transfer fluids, rheology modifiers, scale inhibitors, shale inhibitors, specialty amine solvents, surfactants, water clarifiers, frothing separating agents | Ethylene, methanol, propylene | BASF, Eastman, Hexion, Huntsman, INEOS, LyondellBasell, SABIC, Sasol, Shell |
Polyurethanes & CAV | Aircraft deicing fluids; alumina; pulp and paper; appliances; automotive; bedding; building and construction; flooring; footwear; heat transfer fluids; hydraulic fluids; infrastructure; packaging; textiles and transportation; construction; caulks and sealants; cement-based tile adhesives; concrete solutions; elastomeric roof coatings; industrial non-wovens; plasters and renders; roof tiles and siding; sport grounds and tape joint compounds | Aniline, caustic soda, ethylene dichloride, methylene diphenyl diisocyanate (“MDI”), polyether polyols, propylene glycol, propylene oxide, polyurethane systems, toluene diisocyanate (“TDI”), vinyl chloride monomer, AQUASET™ Acrylic Thermosetting Resins, DOW™ Latex Powder, RHOPLEX™ and PRIMAL™ Acrylic Emulsion Polymers, WALOCEL™ Cellulose Ethers | Acetone, aniline, aqueous hydrochloric acid, chlorine, electric power, ethylene, hydrogen peroxide, propylene, styrene | Arkema, Ashland, BASF, Covestro, Eastman, Huntsman, INEOS, Olin, Owens-Corning, Yantai Wanhua |
• | EQUATE Petrochemical Company K.S.C.C. (“EQUATE”) - a Kuwait-based company that manufactures ethylene, polyethylene and ethylene glycol, and manufactures and markets monoethylene glycol, diethylene glycol and polyethylene terephthalate resins; owned 42.5 percent by Dow. |
• | The Kuwait Olefins Company K.S.C.C. (“TKOC”) - a Kuwait-based company that manufactures ethylene and ethylene glycol; owned 42.5 percent by Dow. |
• | Map Ta Phut Olefins Company Limited (“Map Ta Phut”) - a Thailand-based company that manufactures propylene and ethylene; Dow has an effective ownership of 32.77 percent (of which 20.27 percent is owned directly by Dow and aligned with the Industrial Intermediates & Infrastructure segment and 12.5 percent is owned indirectly through Dow’s equity interest in Siam Polyethylene Company Limited, an entity that is part of The SCG-Dow Group and aligned with the Packaging & Specialty Plastics segment). |
• | Sadara Chemical Company ("Sadara") - a Saudi Arabian company that manufactures chlorine, ethylene, propylene and aromatics for internal consumption and manufactures and sells polyethylene, ethylene oxide and propylene oxide derivative products, and isocyanates; owned 35 percent by Dow. |
Business | Applications/Market Segments | Major Products | Key Raw Materials | Key Competitors |
Hydrocarbons & Energy | Purchaser of feedstocks; production of cost competitive hydrocarbon monomers utilized by Dow derivative businesses; and energy, principally for use in Dow’s global operations | Ethylene, propylene, benzene, butadiene, octene, aromatics co-products, power, steam, other utilities | Butane, condensate, ethane, naphtha, natural gas, propane | Chevron Phillips Chemical, ExxonMobil, INEOS, LyondellBasell, SABIC, Shell, Sinopec |
Packaging and Specialty Plastics | Adhesives; construction; cosmetics; electrical transmission and distribution; food and supply chain packaging; footwear; housewares; health and hygiene; industrial specialty applications using polyolefin elastomers, ethylene copolymers, and ethylene propylene diene monomer elastomers; irrigation pipe; photovoltaic encapsulants; sporting goods; telecommunications infrastructure; toys and infant products | Acrylics, bio-based plasticizers, elastomers, ethylene copolymer resins, EPDM, ethylene vinyl acetate copolymer, methacrylic acid copolymer resins, polyethylene, high-density polyethylene, low-density polyethylene ("LDPE"), linear low-density polyethylene, polyolefin plastomers, resin additives and modifiers, semiconductive and jacketing compound solutions and wire and cable insulation | Ethylene, hexene, octene, propylene | Borealis, ExxonMobil, Ineos, Lanxess, LyondellBasell, Nova, SABIC |
• | The Kuwait Styrene Company K.S.C.C. (“TKSC”) - a Kuwait-based company that manufactures styrene monomer; owned 42.5 percent by Dow. |
• | The SCG-Dow Group - a group of Thailand-based companies (consisting of Siam Polyethylene Company Limited; Siam Polystyrene Company Limited; Siam Styrene Monomer Co., Ltd.; and Siam Synthetic Latex Company Limited) that manufacture polyethylene, polystyrene, styrene, latex and specialty elastomers; owned 50 percent by Dow. |
• | The impact of changing Dow's practice of transferring ethylene to its downstream derivative businesses at cost to transferring ethylene at market-based prices; |
• | Corporate segment allocation/policy changes: |
◦ | The allocation of Corporate segment depreciation expense to the operating segments due to allocating more leveraged assets from the Corporate segment to the operating segments; |
◦ | The inclusion of foreign exchange gains (losses) in segment pro forma Operating EBIT and pro forma Operating EBITDA results; and |
◦ | Stranded costs, previously aligned with the Corporate segment in the Form 10, which are now allocated to the operating segments. |
Three Months Ended | Year Ended | Three Months Ended | Year Ended | Three Months Ended | |||||||||||||||||||||||||||||
In millions | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Dec 31, 2018 | Mar 31, 2019 | ||||||||||||||||||||||
Pro forma net sales by segment | |||||||||||||||||||||||||||||||||
Performance Materials & Coatings | $ | 2,102 | $ | 2,294 | $ | 2,256 | $ | 2,240 | $ | 8,892 | $ | 2,371 | $ | 2,673 | $ | 2,552 | $ | 2,269 | $ | 9,865 | $ | 2,320 | |||||||||||
Industrial Intermediates & Infrastructure | 2,924 | 3,084 | 3,309 | 3,634 | 12,951 | 3,803 | 3,972 | 3,913 | 3,777 | 15,465 | 3,489 | ||||||||||||||||||||||
Packaging & Specialty Plastics | 5,424 | 5,463 | 5,532 | 6,127 | 22,546 | 6,048 | 6,134 | 6,157 | 5,898 | 24,237 | 5,138 | ||||||||||||||||||||||
Corporate | 71 | 95 | 157 | 60 | 383 | 74 | 72 | 75 | 64 | 285 | 69 | ||||||||||||||||||||||
Total | $ | 10,521 | $ | 10,936 | $ | 11,254 | $ | 12,061 | $ | 44,772 | $ | 12,296 | $ | 12,851 | $ | 12,697 | $ | 12,008 | $ | 49,852 | $ | 11,016 | |||||||||||
Pro forma operating EBIT by segment | |||||||||||||||||||||||||||||||||
Performance Materials & Coatings | $ | 154 | $ | 276 | $ | 228 | $ | 159 | $ | 817 | $ | 355 | $ | 292 | $ | 398 | $ | 201 | $ | 1,246 | $ | 271 | |||||||||||
Industrial Intermediates & Infrastructure | 284 | 211 | 496 | 479 | 1,470 | 460 | 502 | 466 | 339 | 1,767 | 277 | ||||||||||||||||||||||
Packaging & Specialty Plastics | 904 | 968 | 880 | 960 | 3,712 | 971 | 926 | 857 | 839 | 3,593 | 690 | ||||||||||||||||||||||
Corporate | (101 | ) | (103 | ) | (118 | ) | (100 | ) | (422 | ) | (89 | ) | (81 | ) | (110 | ) | (90 | ) | (370 | ) | (95 | ) | |||||||||||
Total | $ | 1,241 | $ | 1,352 | $ | 1,486 | $ | 1,498 | $ | 5,577 | $ | 1,697 | $ | 1,639 | $ | 1,611 | $ | 1,289 | $ | 6,236 | $ | 1,143 | |||||||||||
Pro forma depreciation and amortization by segment | |||||||||||||||||||||||||||||||||
Performance Materials & Coatings | $ | 221 | $ | 211 | $ | 226 | $ | 228 | $ | 886 | $ | 222 | $ | 220 | $ | 222 | $ | 224 | $ | 888 | $ | 219 | |||||||||||
Industrial Intermediates & Infrastructure | 151 | 130 | 142 | 149 | 572 | 147 | 152 | 149 | 159 | 607 | 145 | ||||||||||||||||||||||
Packaging & Specialty Plastics | 280 | 268 | 309 | 335 | 1,192 | 352 | 344 | 352 | 337 | 1,385 | 367 | ||||||||||||||||||||||
Corporate | 9 | 8 | 8 | 9 | 34 | 7 | 7 | 9 | 6 | 29 | 12 | ||||||||||||||||||||||
Total | $ | 661 | $ | 617 | $ | 685 | $ | 721 | $ | 2,684 | $ | 728 | $ | 723 | $ | 732 | $ | 726 | $ | 2,909 | $ | 743 | |||||||||||
Pro forma operating EBITDA by segment | |||||||||||||||||||||||||||||||||
Performance Materials & Coatings | $ | 375 | $ | 487 | $ | 454 | $ | 387 | $ | 1,703 | $ | 577 | $ | 512 | $ | 620 | $ | 425 | $ | 2,134 | $ | 490 | |||||||||||
Industrial Intermediates & Infrastructure | 435 | 341 | 638 | 628 | 2,042 | 607 | 654 | 615 | 498 | 2,374 | 422 | ||||||||||||||||||||||
Packaging & Specialty Plastics | 1,184 | 1,236 | 1,189 | 1,295 | 4,904 | 1,323 | 1,270 | 1,209 | 1,176 | 4,978 | 1,057 | ||||||||||||||||||||||
Corporate | (92 | ) | (95 | ) | (110 | ) | (91 | ) | (388 | ) | (82 | ) | (74 | ) | (101 | ) | (84 | ) | (341 | ) | (83 | ) | |||||||||||
Total | $ | 1,902 | $ | 1,969 | $ | 2,171 | $ | 2,219 | $ | 8,261 | $ | 2,425 | $ | 2,362 | $ | 2,343 | $ | 2,015 | $ | 9,145 | $ | 1,886 | |||||||||||
Pro forma equity in earnings (losses) of nonconsolidated affiliates by segment | |||||||||||||||||||||||||||||||||
Performance Materials & Coatings | $ | 12 | $ | 10 | $ | 9 | $ | 9 | $ | 40 | $ | — | $ | 1 | $ | 3 | $ | — | $ | 4 | $ | — | |||||||||||
Industrial Intermediates & Infrastructure | 73 | (13 | ) | 41 | 71 | 172 | 149 | 96 | 54 | (15 | ) | 284 | (48 | ) | |||||||||||||||||||
Packaging & Specialty Plastics | 32 | 37 | 66 | 59 | 194 | 59 | 108 | 83 | 37 | 287 | 38 | ||||||||||||||||||||||
Corporate | (7 | ) | (12 | ) | 12 | (1 | ) | (8 | ) | (7 | ) | (12 | ) | (5 | ) | 4 | (20 | ) | (4 | ) | |||||||||||||
Total | $ | 110 | $ | 22 | $ | 128 | $ | 138 | $ | 398 | $ | 201 | $ | 193 | $ | 135 | $ | 26 | $ | 555 | $ | (14 | ) |
Pro Forma Net Sales by Geographic Region | Three Months Ended | Year Ended | Three Months Ended | Year Ended | Three Months Ended | ||||||||||||||||||||||||||||
In millions | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Dec 31, 2018 | Mar 31, 2019 | ||||||||||||||||||||||
U.S. & Canada | $ | 4,185 | $ | 4,160 | $ | 4,188 | $ | 4,445 | $ | 16,978 | $ | 4,485 | $ | 4,601 | $ | 4,658 | $ | 4,255 | $ | 17,999 | $ | 3,966 | |||||||||||
EMEAI | 3,559 | 3,814 | 3,937 | 4,185 | 15,495 | 4,404 | 4,476 | 4,390 | 4,156 | 17,426 | 3,888 | ||||||||||||||||||||||
Asia Pacific | 1,720 | 1,816 | 1,964 | 2,231 | 7,731 | 2,197 | 2,487 | 2,372 | 2,382 | 9,438 | 2,108 | ||||||||||||||||||||||
Latin America | 1,057 | 1,146 | 1,165 | 1,200 | 4,568 | 1,210 | 1,287 | 1,277 | 1,215 | 4,989 | 1,054 | ||||||||||||||||||||||
Total | $ | 10,521 | $ | 10,936 | $ | 11,254 | $ | 12,061 | $ | 44,772 | $ | 12,296 | $ | 12,851 | $ | 12,697 | $ | 12,008 | $ | 49,852 | $ | 11,016 |
Reconciliation of "Pro forma net income (loss) from continuing operations" to Pro Forma Operating EBIT and Pro Forma Operating EBITDA | Three Months Ended | Year Ended | Three Months Ended | Year Ended | Three Months Ended | ||||||||||||||||||||||||||||
In millions | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Dec 31, 2018 | Mar 31, 2019 | ||||||||||||||||||||||
Pro forma net income (loss) from continuing operations | $ | 685 | $ | 860 | $ | 468 | $ | (2,584 | ) | $ | (571 | ) | $ | 961 | $ | 849 | $ | 743 | $ | 531 | $ | 3,084 | $ | 208 | |||||||||
+ Provision for income taxes | 219 | 276 | 460 | 972 | 1,927 | 236 | 261 | 288 | 62 | 847 | 156 | ||||||||||||||||||||||
Pro forma income (loss) from continuing operations before income taxes | $ | 904 | $ | 1,136 | $ | 928 | $ | (1,612 | ) | $ | 1,356 | $ | 1,197 | $ | 1,110 | $ | 1,031 | $ | 593 | $ | 3,931 | $ | 364 | ||||||||||
- Interest income | 16 | 12 | 17 | 21 | 66 | 20 | 19 | 21 | 23 | 83 | 19 | ||||||||||||||||||||||
+ Interest expense and amortization of debt discount | 213 | 217 | 235 | 250 | 915 | 261 | 262 | 258 | 281 | 1,062 | 240 | ||||||||||||||||||||||
- Adjusted significant items 1 | (140 | ) | (11 | ) | (340 | ) | (2,881 | ) | (3,372 | ) | (259 | ) | (286 | ) | (343 | ) | (438 | ) | (1,326 | ) | (558 | ) | |||||||||||
Pro Forma Operating EBIT (Non-GAAP) | $ | 1,241 | $ | 1,352 | $ | 1,486 | $ | 1,498 | $ | 5,577 | $ | 1,697 | $ | 1,639 | $ | 1,611 | $ | 1,289 | $ | 6,236 | $ | 1,143 | |||||||||||
+ Depreciation and amortization | 661 | 617 | 685 | 721 | 2,684 | 728 | 723 | 732 | 726 | 2,909 | 743 | ||||||||||||||||||||||
Pro Forma Operating EBITDA (Non-GAAP) | $ | 1,902 | $ | 1,969 | $ | 2,171 | $ | 2,219 | $ | 8,261 | $ | 2,425 | $ | 2,362 | $ | 2,343 | $ | 2,015 | $ | 9,145 | $ | 1,886 |
1. | Significant items, excluding the impact of one-time transactions costs directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions and eliminated from the pro forma results. |
Three Months Ended | Year Ended | Three Months Ended | Year Ended | Three Months Ended | |||||||||||||||||||||||||||||
In millions | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Dec 31, 2018 | Mar 31, 2019 | ||||||||||||||||||||||
Pro forma significant items 1 | |||||||||||||||||||||||||||||||||
Impact of Dow Silicones ownership restructure | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (20 | ) | $ | — | $ | — | $ | (20 | ) | $ | — | |||||||||
Litigation related charges, awards and adjustments | — | 137 | — | — | 137 | — | — | — | — | — | — | ||||||||||||||||||||||
Integration and separation costs | (114 | ) | (145 | ) | (212 | ) | (245 | ) | (716 | ) | (207 | ) | (234 | ) | (289 | ) | (344 | ) | (1,074 | ) | (402 | ) | |||||||||||
Restructuring, goodwill impairment and asset related (charges) credits, net | — | 12 | (118 | ) | (2,636 | ) | (2,742 | ) | (72 | ) | (32 | ) | (48 | ) | (46 | ) | (198 | ) | (156 | ) | |||||||||||||
Gains on divestitures | — | 7 | — | — | 7 | 20 | — | — | — | 20 | — | ||||||||||||||||||||||
Transaction costs and productivity actions | (26 | ) | (22 | ) | (10 | ) | — | (58 | ) | — | — | — | — | — | — | ||||||||||||||||||
Loss on early extinguishment of debt | — | — | — | — | — | — | — | (6 | ) | (48 | ) | (54 | ) | — | |||||||||||||||||||
Total pro forma significant items before taxes 2 | $ | (140 | ) | $ | (11 | ) | $ | (340 | ) | $ | (2,881 | ) | $ | (3,372 | ) | $ | (259 | ) | $ | (286 | ) | $ | (343 | ) | $ | (438 | ) | $ | (1,326 | ) | $ | (558 | ) |
Tax impact of pro forma significant items 3 | 42 | (1 | ) | 103 | 225 | 369 | 53 | 39 | 50 | 31 | 173 | 82 | |||||||||||||||||||||
Tax only significant items 4 | — | — | (267 | ) | (915 | ) | (1,182 | ) | (7 | ) | — | 17 | 115 | 125 | (77 | ) | |||||||||||||||||
Total pro forma significant items after-tax 5 | $ | (98 | ) | $ | (12 | ) | $ | (504 | ) | $ | (3,571 | ) | $ | (4,185 | ) | $ | (213 | ) | $ | (247 | ) | $ | (276 | ) | $ | (292 | ) | $ | (1,028 | ) | $ | (553 | ) |
1. | Significant items, excluding the impact of one-time transaction costs directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions and eliminated from the pro forma results. |
2. | Impact on "Income (loss) from continuing operations before income taxes." |
3. | The income tax effect for each adjustment was calculated based on the statutory tax rate for the jurisdiction(s) in which the adjustment was taxable or deductible. |
4. | The three months ended September 30, 2017 reflects tax expense of $267 million related to changes in tax attributes resulting from the Merger, including a reduction in a deferred tax asset in Germany and the recognition of deferred tax gains in the United States. The three months ended March 31, 2019 reflects tax expense of $77 million relating to preparation for the separation and distribution. All tax only significant items shown in other periods relate to the effects of U.S. Tax Reform. |
5. | Impact on "Net income (loss) from continuing operations available for Dow Inc. common stockholders." |
Three Months Ended | Year Ended | Three Months Ended | Year Ended | Three Months Ended | |||||||||||||||||||||||||||||
Dollars per share | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Dec 31, 2018 | Mar 31, 2019 | ||||||||||||||||||||||
Pro forma earnings (loss) from continuing operations per common share - diluted 1 | $ | 0.89 | $ | 1.09 | $ | 0.59 | $ | (3.51 | ) | $ | (0.91 | ) | $ | 1.26 | $ | 1.08 | $ | 0.97 | $ | 0.68 | $ | 3.99 | $ | 0.24 | |||||||||
- Earnings (loss) per common share impact of pro forma significant items, after-tax | (0.13 | ) | (0.02 | ) | (0.67 | ) | (4.78 | ) | (5.60 | ) | (0.29 | ) | (0.33 | ) | (0.37 | ) | (0.39 | ) | (1.38 | ) | (0.74 | ) | |||||||||||
Pro forma operating earnings per common share - diluted (Non-GAAP) 2, 3 | $ | 1.02 | $ | 1.11 | $ | 1.26 | $ | 1.27 | $ | 4.69 | $ | 1.55 | $ | 1.41 | $ | 1.34 | $ | 1.07 | $ | 5.37 | $ | 0.98 |
1. | For the three and twelve months ended December 31, 2017, Dow reported “Pro forma net loss from continuing operations available for Dow common stockholders.” In accordance with U.S. GAAP, “Weighted-average common shares outstanding - basic” was used in the calculation of “Pro forma earnings (loss) from continuing operations per common share - diluted.” |
2. | The dilutive effect of options and awards (7.5 million shares) was included in “Pro forma operating earnings per common share - diluted” for the twelve months ended December 31, 2017 as Dow had net income for this period on an operating basis (Non-GAAP). |
3. | Pro Forma Operating Earnings Per Common Share ("Pro Forma Operating EPS"), a non-GAAP measure, is defined as “Pro Forma earnings (loss) from continuing operations per common share - diluted,” excluding the after-tax impact of pro forma significant items. Dow’s management believes this measure provides useful information to investors by offering an additional way of viewing Dow’s results that helps investors identify the underlying earnings of Dow as compared to prior and future periods and its peers. Pro Forma Operating EPS is a financial measure not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP financial measures of performance. |